179 related articles for article (PubMed ID: 35183688)
1. A hypothesis-driven study to comprehensively investigate the association between genetic polymorphisms in EPHX2 gene and cardiovascular diseases: Findings from the UK Biobank.
Zhu X; Li Y; Yu T; Li S; Chen M
Gene; 2022 May; 822():146340. PubMed ID: 35183688
[TBL] [Abstract][Full Text] [Related]
2. Genetically determined serum urate levels and cardiovascular and other diseases in UK Biobank cohort: A phenome-wide mendelian randomization study.
Li X; Meng X; He Y; Spiliopoulou A; Timofeeva M; Wei WQ; Gifford A; Yang T; Varley T; Tzoulaki I; Joshi P; Denny JC; Mckeigue P; Campbell H; Theodoratou E
PLoS Med; 2019 Oct; 16(10):e1002937. PubMed ID: 31626644
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between adenosine receptors and CYP450-derived oxylipins in the modulation of cardiovascular, including coronary reactive hyperemic response.
Nayeem MA; Hanif A; Geldenhuys WJ; Agba S
Pharmacol Ther; 2022 Dec; 240():108213. PubMed ID: 35597366
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the human soluble epoxide hydrolase gene EPHX2 linked to neuronal survival after ischemic injury.
Koerner IP; Jacks R; DeBarber AE; Koop D; Mao P; Grant DF; Alkayed NJ
J Neurosci; 2007 Apr; 27(17):4642-9. PubMed ID: 17460077
[TBL] [Abstract][Full Text] [Related]
5. Epoxyeicosatrienoic Acids are Mediated by EPHX2 Variants and may be a Predictor of Early Neurological Deterioration in Acute Minor Ischemic Stroke.
Yi X; Lin J; Li J; Zhou Q; Han Z
J Atheroscler Thromb; 2017 Dec; 24(12):1258-1266. PubMed ID: 28835580
[TBL] [Abstract][Full Text] [Related]
6. Homozygosity for the EPHX2 K55R polymorphism increases the long-term risk of ischemic stroke in men: a study in Swedes.
Fava C; Montagnana M; Danese E; Almgren P; Hedblad B; Engström G; Berglund G; Minuz P; Melander O
Pharmacogenet Genomics; 2010 Feb; 20(2):94-103. PubMed ID: 20065888
[TBL] [Abstract][Full Text] [Related]
7. No impact of soluble epoxide hydrolase rs4149243, rs2234914 and rs751142 genetic variants on the development of type II diabetes and its hypertensive complication among Jordanian patients.
Khamees M; Jarrar Y; Al-Qirim T; Mahmoud IS; Hatmal MM; Alshaer W; Lee SJ
Int J Clin Pract; 2021 May; 75(5):e14036. PubMed ID: 33512081
[TBL] [Abstract][Full Text] [Related]
8. Altered soluble epoxide hydrolase gene expression and function and vascular disease risk in the stroke-prone spontaneously hypertensive rat.
Corenblum MJ; Wise VE; Georgi K; Hammock BD; Doris PA; Fornage M
Hypertension; 2008 Feb; 51(2):567-73. PubMed ID: 18086949
[TBL] [Abstract][Full Text] [Related]
9. Genetic analysis of the soluble epoxide hydrolase gene, EPHX2, in subclinical cardiovascular disease in the Diabetes Heart Study.
Burdon KP; Lehtinen AB; Langefeld CD; Carr JJ; Rich SS; Freedman BI; Herrington D; Bowden DW
Diab Vasc Dis Res; 2008 Jun; 5(2):128-34. PubMed ID: 18537101
[TBL] [Abstract][Full Text] [Related]
10. Association between the EPHX2 p.Lys55Arg polymorphism and prognosis following an acute coronary syndrome.
Oni-Orisan A; Cresci S; Jones PG; Theken KN; Spertus JA; Lee CR
Prostaglandins Other Lipid Mediat; 2018 Sep; 138():15-22. PubMed ID: 30096423
[TBL] [Abstract][Full Text] [Related]
11. Arg287Gln variant of EPHX2 and epoxyeicosatrienoic acids are associated with insulin sensitivity in humans.
Ramirez CE; Shuey MM; Milne GL; Gilbert K; Hui N; Yu C; Luther JM; Brown NJ
Prostaglandins Other Lipid Mediat; 2014 Oct; 113-115():38-44. PubMed ID: 25173047
[TBL] [Abstract][Full Text] [Related]
12. A data-driven approach for studying the role of body mass in multiple diseases: a phenome-wide registry-based case-control study in the UK Biobank.
Hyppönen E; Mulugeta A; Zhou A; Santhanakrishnan VK
Lancet Digit Health; 2019 Jul; 1(3):e116-e126. PubMed ID: 33323262
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study.
Lee CR; North KE; Bray MS; Fornage M; Seubert JM; Newman JW; Hammock BD; Couper DJ; Heiss G; Zeldin DC
Hum Mol Genet; 2006 May; 15(10):1640-9. PubMed ID: 16595607
[TBL] [Abstract][Full Text] [Related]
14. Variations in the human soluble epoxide hydrolase gene and recurrence of atrial fibrillation after catheter ablation.
Wutzler A; Kestler C; Perrot A; Loehr L; Huemer M; Parwani AS; Attanasio P; Özcelik C; Schunck WH; Gollasch M; Haverkamp W; Boldt LH
Int J Cardiol; 2013 Oct; 168(4):3647-51. PubMed ID: 23711456
[TBL] [Abstract][Full Text] [Related]
15. Association between the soluble epoxide hydrolase gene and preeclampsia.
Sari I; Pinarbasi H; Pinarbasi E; Yildiz C
Hypertens Pregnancy; 2017 Nov; 36(4):315-325. PubMed ID: 29058492
[TBL] [Abstract][Full Text] [Related]
16. Association between polymorphisms of CYP2J2 and EPHX2 genes and risk of coronary artery disease.
Xu Y; Ding H; Peng J; Cui G; Liu L; Cianflone K; Wang DW
Pharmacogenet Genomics; 2011 Aug; 21(8):489-94. PubMed ID: 21642892
[TBL] [Abstract][Full Text] [Related]
17. Relationship between EPHX2 gene polymorphisms and essential hypertension in Uygur, Kazakh, and Han.
Zhu XL; Wang L; Wang Z; Chen SZ; Zhang WQ; Ma MM
Genet Mol Res; 2015 Apr; 14(2):3474-80. PubMed ID: 25966114
[TBL] [Abstract][Full Text] [Related]
18. Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis.
Li L; Li N; Pang W; Zhang X; Hammock BD; Ai D; Zhu Y
PLoS One; 2014; 9(4):e94092. PubMed ID: 24718617
[TBL] [Abstract][Full Text] [Related]
19. Missense Genetic Polymorphisms of Microsomal (
Can Demirdöğen B; Miçooğulları Y; Türkanoğlu Özçelik A; Adalı O
Neuropsychiatr Dis Treat; 2020; 16():3251-3265. PubMed ID: 33994786
[TBL] [Abstract][Full Text] [Related]
20. Association Study of Genetic Variants in Calcium Signaling-Related Genes With Cardiovascular Diseases.
Li S; Jia Z; Zhang Z; Li Y; Yan M; Yu T
Front Cell Dev Biol; 2021; 9():642141. PubMed ID: 34912794
[No Abstract] [Full Text] [Related]
[Next] [New Search]
